Ubiquitination/ Proteasome
Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
- B6179 VPS34-IN1Summary: Vps34 inhibitor
- C3250 Ubiquitin Isopeptidase Inhibitor ISummary: ubiquitin isopeptidase inhibitor
- A8740 C598-0466Summary: USP7 inhibitor
- C4090 HMB-Val-Ser-Leu-VESummary: inhibitor of the trypsin-like activity of the 20S proteasome
- B1317 ML-323Target: Deubiquitinating enzymes (DUBs)Summary: USP1-UAF1 inhibitor
- B1307 SJB3-019ATarget: USPSummary: Usp1 inhibitor
- B1397 Trifluoperazine 2HClSummary: Dopamine D2 receptor inhibitor
- B1395 Sulfacetamide SodiumSummary: Sulfonamide antibiotic
- B1391 Divalproex SodiumSummary: Epilepsy/migraines/bipolar disorder medicine
- A2571 Pepstatin A1 CitationTarget: Cathepsins|Renin|HIV proteases|PepsinsSummary: aspartic proteases inhibitor